2023-05-012024-04-302024-04-30false11947266CURE PHYSIO LIMITED2024-10-01iso4217:GBPxbrli:pure119472662023-05-01119472662024-04-30119472662023-05-012024-04-30119472662022-05-01119472662023-04-30119472662022-05-012023-04-3011947266bus:SmallEntities2023-05-012024-04-3011947266bus:AuditExempt-NoAccountantsReport2023-05-012024-04-3011947266bus:AbridgedAccounts2023-05-012024-04-3011947266bus:PrivateLimitedCompanyLtd2023-05-012024-04-3011947266core:WithinOneYear2024-04-3011947266core:AfterOneYear2024-04-3011947266core:WithinOneYear2023-04-3011947266core:AfterOneYear2023-04-3011947266core:ShareCapital2024-04-3011947266core:SharePremium2024-04-3011947266core:RevaluationReserve2024-04-3011947266core:OtherReservesSubtotal2024-04-3011947266core:RetainedEarningsAccumulatedLosses2024-04-3011947266core:ShareCapital2023-04-3011947266core:SharePremium2023-04-3011947266core:RevaluationReserve2023-04-3011947266core:OtherReservesSubtotal2023-04-3011947266core:RetainedEarningsAccumulatedLosses2023-04-3011947266core:LandBuildings2024-04-3011947266core:PlantMachinery2024-04-3011947266core:Vehicles2024-04-3011947266core:FurnitureFittings2024-04-3011947266core:OfficeEquipment2024-04-3011947266core:NetGoodwill2024-04-3011947266core:IntangibleAssetsOtherThanGoodwill2024-04-3011947266core:ListedExchangeTraded2024-04-3011947266core:UnlistedNon-exchangeTraded2024-04-3011947266core:LandBuildings2023-04-3011947266core:PlantMachinery2023-04-3011947266core:Vehicles2023-04-3011947266core:FurnitureFittings2023-04-3011947266core:OfficeEquipment2023-04-3011947266core:NetGoodwill2023-04-3011947266core:IntangibleAssetsOtherThanGoodwill2023-04-3011947266core:ListedExchangeTraded2023-04-3011947266core:UnlistedNon-exchangeTraded2023-04-3011947266core:LandBuildings2023-05-012024-04-3011947266core:PlantMachinery2023-05-012024-04-3011947266core:Vehicles2023-05-012024-04-3011947266core:FurnitureFittings2023-05-012024-04-3011947266core:OfficeEquipment2023-05-012024-04-3011947266core:NetGoodwill2023-05-012024-04-3011947266core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3011947266core:ListedExchangeTraded2023-05-012024-04-3011947266core:UnlistedNon-exchangeTraded2023-05-012024-04-3011947266core:MoreThanFiveYears2023-05-012024-04-3011947266core:Non-currentFinancialInstruments2024-04-3011947266core:Non-currentFinancialInstruments2023-04-3011947266dpl:CostSales2023-05-012024-04-3011947266dpl:DistributionCosts2023-05-012024-04-3011947266core:LandBuildings2023-05-012024-04-3011947266core:PlantMachinery2023-05-012024-04-3011947266core:Vehicles2023-05-012024-04-3011947266core:FurnitureFittings2023-05-012024-04-3011947266core:OfficeEquipment2023-05-012024-04-3011947266dpl:AdministrativeExpenses2023-05-012024-04-3011947266core:NetGoodwill2023-05-012024-04-3011947266core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3011947266dpl:GroupUndertakings2023-05-012024-04-3011947266dpl:ParticipatingInterests2023-05-012024-04-3011947266dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-012024-04-3011947266core:ListedExchangeTraded2023-05-012024-04-3011947266dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-012024-04-3011947266core:UnlistedNon-exchangeTraded2023-05-012024-04-3011947266dpl:CostSales2022-05-012023-04-3011947266dpl:DistributionCosts2022-05-012023-04-3011947266core:LandBuildings2022-05-012023-04-3011947266core:PlantMachinery2022-05-012023-04-3011947266core:Vehicles2022-05-012023-04-3011947266core:FurnitureFittings2022-05-012023-04-3011947266core:OfficeEquipment2022-05-012023-04-3011947266dpl:AdministrativeExpenses2022-05-012023-04-3011947266core:NetGoodwill2022-05-012023-04-3011947266core:IntangibleAssetsOtherThanGoodwill2022-05-012023-04-3011947266dpl:GroupUndertakings2022-05-012023-04-3011947266dpl:ParticipatingInterests2022-05-012023-04-3011947266dpl:GroupUndertakingscore:ListedExchangeTraded2022-05-012023-04-3011947266core:ListedExchangeTraded2022-05-012023-04-3011947266dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-05-012023-04-3011947266core:UnlistedNon-exchangeTraded2022-05-012023-04-3011947266core:NetGoodwill2024-04-3011947266core:IntangibleAssetsOtherThanGoodwill2024-04-3011947266core:LandBuildings2024-04-3011947266core:PlantMachinery2024-04-3011947266core:Vehicles2024-04-3011947266core:FurnitureFittings2024-04-3011947266core:OfficeEquipment2024-04-3011947266core:AfterOneYear2024-04-3011947266core:WithinOneYear2024-04-3011947266core:ListedExchangeTraded2024-04-3011947266core:UnlistedNon-exchangeTraded2024-04-3011947266core:ShareCapital2024-04-3011947266core:SharePremium2024-04-3011947266core:RevaluationReserve2024-04-3011947266core:OtherReservesSubtotal2024-04-3011947266core:RetainedEarningsAccumulatedLosses2024-04-3011947266core:NetGoodwill2023-04-3011947266core:IntangibleAssetsOtherThanGoodwill2023-04-3011947266core:LandBuildings2023-04-3011947266core:PlantMachinery2023-04-3011947266core:Vehicles2023-04-3011947266core:FurnitureFittings2023-04-3011947266core:OfficeEquipment2023-04-3011947266core:AfterOneYear2023-04-3011947266core:WithinOneYear2023-04-3011947266core:ListedExchangeTraded2023-04-3011947266core:UnlistedNon-exchangeTraded2023-04-3011947266core:ShareCapital2023-04-3011947266core:SharePremium2023-04-3011947266core:RevaluationReserve2023-04-3011947266core:OtherReservesSubtotal2023-04-3011947266core:RetainedEarningsAccumulatedLosses2023-04-3011947266core:NetGoodwill2022-05-0111947266core:IntangibleAssetsOtherThanGoodwill2022-05-0111947266core:LandBuildings2022-05-0111947266core:PlantMachinery2022-05-0111947266core:Vehicles2022-05-0111947266core:FurnitureFittings2022-05-0111947266core:OfficeEquipment2022-05-0111947266core:AfterOneYear2022-05-0111947266core:WithinOneYear2022-05-0111947266core:ListedExchangeTraded2022-05-0111947266core:UnlistedNon-exchangeTraded2022-05-0111947266core:ShareCapital2022-05-0111947266core:SharePremium2022-05-0111947266core:RevaluationReserve2022-05-0111947266core:OtherReservesSubtotal2022-05-0111947266core:RetainedEarningsAccumulatedLosses2022-05-0111947266core:AfterOneYear2023-05-012024-04-3011947266core:WithinOneYear2023-05-012024-04-3011947266core:Non-currentFinancialInstrumentscore:CostValuation2023-05-012024-04-3011947266core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-012024-04-3011947266core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-012024-04-3011947266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-012024-04-3011947266core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-012024-04-3011947266core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-012024-04-3011947266core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3011947266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3011947266core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3011947266core:Non-currentFinancialInstrumentscore:CostValuation2024-04-3011947266core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-3011947266core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-3011947266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-3011947266core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-3011947266core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-3011947266core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-3011947266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-3011947266core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-3011947266core:Non-currentFinancialInstrumentscore:CostValuation2023-04-3011947266core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-3011947266core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-3011947266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-3011947266core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-3011947266core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-3011947266core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-3011947266core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-3011947266core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-3011947266bus:Director12023-05-012024-04-30

CURE PHYSIO LIMITED

Registered Number
11947266
(England and Wales)

Unaudited Financial Statements for the Year ended
30 April 2024

CURE PHYSIO LIMITED
Company Information
for the year from 1 May 2023 to 30 April 2024

Director

Jonathan Wride

Registered Address

The Old Smithy Stocktons Courtyard
Overbury
Tewkesbury
GL20 7NT

Place of Business

52 Moorend Road

Cheltenham

GL53 0HD


Registered Number

11947266 (England and Wales)
CURE PHYSIO LIMITED
Balance Sheet as at
30 April 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets310,00010,000
Tangible assets42,485725
12,48510,725
Current assets
Debtors31,51014,663
Cash at bank and on hand25,30177,775
56,81192,438
Creditors amounts falling due within one year(30,326)(28,655)
Net current assets (liabilities)26,48563,783
Total assets less current liabilities38,97074,508
Net assets38,97074,508
Capital and reserves
Called up share capital100100
Profit and loss account38,87074,408
Shareholders' funds38,97074,508
The financial statements were approved and authorised for issue by the Director on 1 October 2024, and are signed on its behalf by:
Jonathan Wride
Director
Registered Company No. 11947266
CURE PHYSIO LIMITED
Notes to the Financial Statements
for the year ended 30 April 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Intangible assets
Intangible assets represents the goodwill of the business and it reviewed each year.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Plant and machinery25
2.Average number of employees

20242023
Average number of employees during the year12
3.Intangible assets

Total

£
Cost or valuation
At 01 May 2310,000
At 30 April 2410,000
Net book value
At 30 April 2410,000
At 30 April 2310,000
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 May 2314,554
Additions2,757
At 30 April 2417,311
Depreciation and impairment
At 01 May 2313,828
Charge for year998
At 30 April 2414,826
Net book value
At 30 April 242,485
At 30 April 23725